Contact
Biography
Stuart Carroll is a senior health economist, epidemiologist, and health policy expert specialising in the NHS; infectious diseases, vaccines and public health; the pharmaceutical industry; and public and external affairs. His areas of expertise include vaccination policy and public health systems; healthcare funding and pricing and reimbursement; market access strategy and health technology appraisal (HTA); and industrial policy including strategic communications and government affairs. Stuart holds an MBA (with distinction) from Imperial Business School, an MSc in Health Economics (with distinction) from the University of York and a BA (Hons) in Politics and Economics from the University of Northumbria at Newcastle (1st Class).
Expertise Summary
Stuart has experience leading and managing over 50 HTA and tender submissions to a range of global health authorities; building new teams from scratch with over 12 years of line management and leadership experience; and formulating strategic and commercial plans. He has worked across multiple areas of health and industrial policy including vaccination, oncology, neurology, rare diseases, mental health and the UK Voluntary Scheme for Branded Medicines (VPAS). Stuart has been a voting member of the New Drugs Committee (NDC) for the Scottish Medicines Consortium (SMC) and the National Institute for Health & Care Excellence (NICE) Appeals Panel. He is currently a Senior Fellow at the Office of Health Economics.
Stuart currrently works as Director for Market Access and Policy Affairs for Moderna UK and Ireland. He previously worked as a Senior Expert Policy and Strategy Adviser for the UK Government's Vaccines Taskforce, Therapeutic Taskforce and Antiviral Taskforce, where he was responsible for leading and coordinating interactions with manufacturers, NHS England, MHRA and NIBSC, JCVI, PHE, DHSC and BEIS, and the Northern Irish Office and Cabinet Office. Stuart was also an elected Borough Councillor for Boyn Hill in the Royal Borough of Windsor & Maidenhead (RBWM) from 2015 to 20233, hacving served as the Deputy Chair of Cabinet and the Cabinet Member for Adult Social Care, Health, Mental Health and Children Services. Stuart also holds a Senior Fellowship at the think tank Policy Exchange and a Senior Visiting Fellowship at the Office of Health Economics. Stuart's PhD is sponsored by the Office of Health Economics via an independent and unrestricted grant.
Research Summary
PhD candidate in Social Policy focusing on public health and COVID-19 pandemic. Research title: Science and The State: The Role of Politics and Policy in the Procurement of Covid-19 Vaccines in the… read more
Current Research
PhD candidate in Social Policy focusing on public health and COVID-19 pandemic. Research title: Science and The State: The Role of Politics and Policy in the Procurement of Covid-19 Vaccines in the Coronavirus Pandemic
Past Research
Carroll SM (2014), Is the Health Economist's Toolkit Adequately Equipped for Economic Evaluations of Preventative Healthcare in the UK?, Imperial College Business School, 2014.
Carroll SM (2005), An Exploration of Provider Reimbursement: Issues and Options for Reform in the Malaysian Healthcare System, York University Library, September 2005. 145.
Carroll SM (2004), The Reinvention of US Hegemony: US Structural Power in the International Political Economy, Northumbria University Library Press, June 2004.
Future Research
The interactions between policy, politics, procurement and the COVID-19 pandemic.